nivolumab,ipilimumab
bms
['lung', 'text,(-texte),(-texti)', 'optima']
all #esmo22 sessions w/ great lively q&amp;a (&amp; never enough time for all to be covered!). here, from at contextualizing findings from ifct-1701 on key issue of optimal duration io, in oral lung session (thoughtful discussion by ) 
Thoracic medical oncologist, lung cancer researcher, @MGHCancerCenter. Views my own.